Literature DB >> 7814300

Functional 5-HT receptor subtypes in the isolated canine common carotid artery.

S Vhora1, S Chiba.   

Abstract

The vascular responses to 5-hydroxytrypamine (5-HT), 5-carboxamidotryptamine (5-CT, a selective 5-HT1-like receptor agonist), alpha-methyl-5-HT (alpha-M-5-HT, a relatively selective 5-HT2 receptor agonist), noradrenaline (NA), and KCl were examined in isolated, cannulated, and perfused canine common carotid arterial preparations. They caused strong vasoconstrictions. The rank order of vasoconstrictive potency was 5-HT > alpha-M-5-HT > or = NA > 5-CT >> KCl. The 5-HT-induced vasoconstriction was significantly depressed by methysergide (a 5-HT1 and 5-HT2 receptor antagonist), ketanserin (a selective 5-HT2 receptor antagonist), and spiperone (a selective 5-HT2 receptor antagonist). The 5-CT- and alpha-M-5-HT-induced vasoconstrictions were also significantly inhibited by methysergide, spiperone, and ketanserin. The NA-induced vasoconstriction was readily inhibited by bunazosin (an alpha-adrenoceptor antagonist) and ketanserin but not significantly inhibited by spiperone and methysergide. KCl has a weak potency for producing a vasoconstriction of the canine common carotid artery. A relatively large dose of diltiazem (a calcium channel-blocker) did not modify 5-HT-induced vasoconstrictions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814300     DOI: 10.1007/bf01745103

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

Review 1.  The 5-HT4 receptor: a place in the sun.

Authors:  J Bockaert; J R Fozard; A Dumuis; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

2.  Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery.

Authors:  D S Houston; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

Review 3.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

Review 4.  Serotonergic receptor subtypes and vascular reactivity.

Authors:  J M Van Nueten; J E Leysen; F de Clerck; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

Review 5.  5-HT(1)-like receptor agonists and the pathophysiology of migraine.

Authors:  P R Saxena; M D Ferrari
Journal:  Trends Pharmacol Sci       Date:  1989-05       Impact factor: 14.819

6.  Agonist action of yohimbine on the perfused rabbit central ear artery.

Authors:  F M Tayo
Journal:  Blood Vessels       Date:  1982

7.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

8.  Characterization of 5-HT receptors in simian isolated gastroepiploic artery.

Authors:  M Noguchi; T Nakane; S Chiba
Journal:  Eur J Pharmacol       Date:  1993-03-30       Impact factor: 4.432

9.  Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries?

Authors:  T F Lüscher; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

10.  Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen.

Authors:  P R Saxena; N A Koedam; J Heiligers; R P Hof
Journal:  Cephalalgia       Date:  1983-06       Impact factor: 6.292

View more
  2 in total

1.  Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.

Authors:  I S Geerts; K E Matthys; A G Herman; H Bult
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Collar-induced elevation of mRNA and functional activity of 5-HT(1B) receptor in the rabbit carotid artery.

Authors:  I S Geerts; G R De Meyer; H Bult
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.